Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.
Despite increasing concern about drug-resistant herpes simplex virus (HSV), antiviral susceptibility testing is not routinely performed by most clinical virology laboratories. This omission is in large part because the most widely accepted method, the plaque reduction assay (PRA), is cumbersome to p...
Furkejuvvon:
| Publikašuvnnas: | Antimicrob Agents Chemother |
|---|---|
| Váldodahkkit: | , , |
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
American Society for Microbiology (ASM)
1995
|
| Fáttát: | |
| Liŋkkat: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162728/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574517/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1287 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
